Nephrocare Health Services Complete Financial Statements
In FY2025, Nephrocare Health Services (NEPHROPLUS) reported revenue ₹250 Cr, net profit ₹-10 Cr and EPS ₹-1.12, with a net profit margin of -4.0% and ROE of -1.7%. Full financial statements from FY2021 to FY2025 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore NEPHROPLUS fundamental worth to estimate fundamental worth using multiple valuation models.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
NEPHROPLUS Revenue, Net Profit & EBITDA — Year-on-Year Growth
NEPHROPLUS YoY (Dec 2024 vs Sept 2025) — revenue +23.2%, net profit -150.0%, EBITDA +36.0%, expenses +19.0%. Review NEPHROPLUS PE ratio trends to evaluate earnings-based valuation against sector peers.
NEPHROPLUS Income Statement — Revenue, EBITDA & Net Profit
Nephrocare Health Services revenue ₹250 Cr, EBITDA ₹68 Cr, net profit ₹-10 Cr, EPS ₹-1.12 (2025) — net profit margin -4.0%. For live price, earnings ratios and company overview, see Nephrocare Health Services screener.
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Revenue | 250 | 223 | 234 | 263 | 203 |
| Expenses | 182 | 168 | 180 | 199 | 153 |
| EBITDA | 68 | 55 | 54 | 64 | 50 |
| Operating Profit Margin % | 26.00% | 23.00% | 21.00% | 23.00% | 22.00% |
| Depreciation | 23 | 19 | 20 | 22 | 18 |
| Interest | 45 | 6 | 6 | 6 | 5 |
| Profit Before Tax | -1 | 30 | 29 | 36 | 26 |
| Tax | 9 | 5 | 5 | 4 | 6 |
| Net Profit | -10 | 25 | 24 | 32 | 20 |
| Earnings Per Share (₹) | -1.12 | 140.89 | 13.10 | 3.43 | 2.47 |
NEPHROPLUS Balance Sheet — Assets, Liabilities & Shareholders' Equity
NEPHROPLUS total assets ₹997 Cr, total equity ₹584 Cr, total liabilities ₹ Cr (2025) — ROE -1.7%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 997 | 806 | 666 | 571 | 428 |
| Current Assets | 545 | 390 | 324 | 285 | 178 |
| Fixed Assets | 396 | 356 | 239 | 205 | 192 |
| Capital Work in Progress | 6 | 1 | 34 | 43 | 2 |
| Investments | 51 | 0 | 0 | 0 | 0 |
| Other Assets | 544 | 450 | 393 | 322 | 234 |
| LIABILITIES | |||||
| Total Liabilities | |||||
| Current Liabilities | 129 | 150 | 103 | 81 | 75 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 584 | 414 | 389 | 396 | 259 |
| Share Capital | 2 | 2 | 5 | 5 | 4 |
| Reserves & Surplus | 579 | 409 | 384 | 387 | 245 |
NEPHROPLUS Cash Flow Statement — Operating, Investing & Financing
Nephrocare Health Services operating cash flow ₹135 Cr, investing ₹-125 Cr, financing ₹54 Cr, net cash flow ₹65 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Operating Activities | 135 | 72 | 11 | 14 | 32 |
| Investing Activities | -125 | -52 | -76 | -130 | -62 |
| Financing Activities | 54 | 27 | 60 | 121 | 36 |
| Net Cash Flow | 65 | 47 | -5 | 6 | 5 |